An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-4 | Issue-10
Adrenal tumours: Five years audit in a tertiary care centre
Dilip Kumar Pal, Vipin Chandra
Published: Oct. 31, 2016 | 208 131
DOI: 10.36347/sjams.2016.v04i10.045
Pages: 3782-3786
Downloads
Abstract
Adrenal gland is not handled routinely by the urologist because it is not so common. Surgical indications are not clearly defined. We present here the cases of adrenals who had undergone surgery for various indications in last 5 years and will try to correlate with the mode of detection, its functional status, histopathological (HPE) reports and outcome after surgery.It is a retrospective study. Data of 52 patients were collected who had undergone adrenal surgery either unilateral or bilateral. Various parameters such as gender, age, size of the tumor functional status, histopathology, type of management and outcome have been reviewed. A total of 52 patients of adrenal lesions were studied retrospectively during 2010 to 2015. All cases were admitted in urology department either by outdoor basis or by transfer from endocrinology department. Twenty three patients were male and 29 were female. Mean age of the patient was 32.9 years (01 -62 years). Mean size of tumor was 4.98 cm (2.2 cm to 12.3 cm). For benign tumor mean size was 4.2 cm and for malignant tumor it was 7.28 cm. There were 47 benign cases and 5 malignant cases. One case was of adrenal Ewing’s sarcoma (ES) in an 8 year old girl, very rare case. There were 23 of adenoma, 9 cases of myelolipoma, 7 cases of cyst, 5 cases of phaeochromocytoma, 2 cases of teratoma and 1 case of recurrent pituitary microadenoma. Among malignant tumor 4 cases of adreno-cortical carcinoma and 1 case of adrenal ES. There were 15 functional adrenal lesions (28.4%) out of 52 cases. Despite incidentally detected, adrenal lesion need proper evaluation with the help of endocrinologist. Benign conditions get cured after surgery and in malignancy survival depends upon extent of lesion and metastatic status of the tumor.